Tang Kevin Insider Trades

Insider Trading History

Track insider trading activity for Tang Kevin. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $219M 12,229,500 shares
Last Trade
Mar 03, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.62M 184,208 shares
$14.22
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $213M 11,929,500 shares
Last Trade
Mar 02, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.2M 83,561 shares
$14.33
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $215M 12,045,292 shares
Last Trade
Mar 02, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.65M 115,792 shares
$14.21
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $208M 11,629,500 shares
Last Trade
Feb 27, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.17M 300,000 shares
$13.90
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $212M 11,844,339 shares
Last Trade
Feb 27, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.03M 214,839 shares
$14.12
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $212M 11,845,939 shares
Last Trade
Feb 27, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$23k 1,600 shares
$14.38
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $203M 11,329,500 shares
Last Trade
Aug 05, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.34M 200,000 shares
$11.68
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $199M 11,129,500 shares
Last Trade
Aug 04, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.13M 100,000 shares
$11.34
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $197M 11,029,500 shares
Last Trade
Aug 01, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.1M 1,000,000 shares
$10.12
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $179M 10,029,500 shares
Last Trade
Mar 04, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.95M 748,038 shares
$7.96
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $166M 9,281,462 shares
Last Trade
Mar 03, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.63M 452,682 shares
$8.01
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $158M 8,828,780 shares
Last Trade
Feb 28, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.13M 399,280 shares
$7.85
$17.88
Singular Genomics Systems
Singular Genomics Systems OMIC
10% owner
Holding Value $0 0 shares
Last Trade
Feb 21, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$7.44M 372,000 shares
$20.00
$20.01
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $151M 8,429,500 shares
Last Trade
Dec 09, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.55M 500,000 shares
$9.09
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $142M 7,929,500 shares
Last Trade
Dec 06, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.6M 400,000 shares
$9.01
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $135M 7,529,500 shares
Last Trade
Dec 05, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.67M 300,000 shares
$8.91
$17.88
Singular Genomics Systems
Singular Genomics Systems OMIC
10% owner
Holding Value $7.44M 372,000 shares
Last Trade
Sep 18, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$551k 32,000 shares
$17.21
$20.01
Singular Genomics Systems
Singular Genomics Systems OMIC
10% owner
Holding Value $6.8M 340,000 shares
Last Trade
Sep 17, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$613k 40,000 shares
$15.33
$20.01
Singular Genomics Systems
Singular Genomics Systems OMIC
10% owner
Holding Value $6M 300,000 shares
Last Trade
Sep 16, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$642k 50,416 shares
$12.74
$20.01
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $129M 7,229,500 shares
Last Trade
Sep 12, 2024 Sale
$18M 3,000,000 shares
$6.00
$17.88

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up